Related Experiment Video
Updated: Jun 5, 2026
Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
Published on: August 23, 2016
PEG-PCL nanoparticles loaded with amazonian compounds inhibit Zika virus replication and modulate host immune
Alice de Freitas Gomes1, Giovanni Dal Poggetto2, Carlos Eduardo de Castro Alves3
1Post-Graduate Program in Basic and Applied Immunology, Institute of Biological Science, Federal University of Amazonas, Manaus, AM, Brazil; Laboratory of Virology and Immunology, National Institute of Amazonian Research (INPA), Manaus, AM, Brazil.
Nanoencapsulated Amazonian compounds show promise against Zika virus (ZIKV). Zerumbone nanoparticles effectively reduced viral replication and inactivation, offering a potential new therapeutic strategy for ZIKV infections.
Area of Science:
- Natural Product Chemistry
- Nanotechnology
- Virology
- Immunology
Background:
- Zika virus (ZIKV) poses a significant global health threat with no specific antiviral treatments available.
- Amazonian bioactive compounds offer therapeutic potential but face challenges with solubility and stability.
- Developing effective delivery systems is crucial for harnessing the benefits of these natural compounds.
Purpose of the Study:
- To evaluate the antiviral and immunomodulatory effects of Piper alatipetiolatum essential oil and zerumbone encapsulated in PEG-PCL nanoparticles against ZIKV.
- To explore the molecular interactions of these compounds with ZIKV targets.
- To assess the potential of nanoencapsulation for improving the delivery and efficacy of these bioactives.
Main Methods:
- Molecular docking simulations against ZIKV NS5 methyltransferase.
- Antiviral assays (plaque-forming unit assays) at different infection stages (adsorption, replication, inactivation).
- Cytokine profiling (ELISA, ProQuantum assays) in treated peripheral blood mononuclear cells (PBMCs).
Main Results:
- Molecular docking identified ishwarol B as a potential ZIKV NS5 methyltransferase inhibitor.
- Zerumbone-loaded nanoparticles (Z-PEG-PCL) demonstrated potent antiviral activity, achieving 100% reduction in viral replication and inactivation.
- Both nanoformulations modulated cytokine profiles, with distinct dose-dependent effects on IL-6, IL-8, IP-10, TNF-α, and MCP-1.
Conclusions:
- PEG-PCL nanoencapsulation enhances the delivery of Amazonian bioactives for ZIKV intervention.
- The nanoformulations exhibit combined antiviral and immunomodulatory properties.
- This platform presents a promising strategy for developing novel ZIKV therapies.
